Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform.


Journal

JCO oncology practice
ISSN: 2688-1535
Titre abrégé: JCO Oncol Pract
Pays: United States
ID NLM: 101758685

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 10 7 2021
medline: 15 1 2022
entrez: 9 7 2021
Statut: ppublish

Résumé

COVID-19 challenged medical practice and graduate medical education. Building on previous initiatives, we describe and reflect on the formative process and goals of the Hematology-Oncology Collaborative Videoconferencing Learning Initiative, a trainee-led multi-institutional virtual COVID-19 learning model. Clinical fellows and faculty from 13 US training institutions developed consensus needs, goals, and objectives, recruited presenters, and generated a multidisciplinary COVID-19 curriculum. Weekly Zoom conferences consisted of two trainee-led instructional segments and a trainee-moderated faculty Q&A panel. Hematology-oncology training program faculty and trainees were the targeted audience. Leadership evaluations consisted of anonymized baseline and concluding mixed methods surveys. Presenter evaluations consisted of session debriefs and two structured focus groups. Conference evaluations consisted of attendance, demographics, and pre- or postmultiple-choice questions on topic learning objectives. In 6 weeks, the initiative produced five conferences: antivirals, anticoagulation, pulmonology, provider resilience, and resource scarcity ethics. The average attendance was 100 (range 57-185). Among attendees providing both pre- and postconference data, group-level knowledge appeared to increase: antiviral (n = 46) pre-/postcorrect 82.6%/97.8% and incorrect 10.9%/2.2%, anticoagulation (n = 60) pre-/postcorrect 75%/93.3% and incorrect 15%/6.7%, and pulmonary (n = 21) pre-/postcorrect 66.7%/95.2% and incorrect 33.3%/4.8%. Although pulmonary management comfort appeared to increase, comfort managing of antivirals and anticoagulation was unchanged. At the conclusion of the pilot, leadership trainees reported improved self-confidence organizing multi-institutional collaborations, median (interquartile range) 58.5 (50-64) compared with baseline 34 (26-39), but did not report improved confidence in other educational or leadership skills. During crisis, trainees built a multi-institutional virtual education platform for the purposes of sharing pandemic experiences and knowledge. Accomplishment of initiative goals was mixed. Lessons learned from the process and goals may improve future disaster educational initiatives.

Identifiants

pubmed: 34242082
doi: 10.1200/OP.20.00960
pmc: PMC8758064
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e36-e46

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Am J Transplant. 2020 Jul;20(7):1826-1836
pubmed: 32323460
JAMA. 2020 Jun 2;323(21):2131-2132
pubmed: 32232420
Med Lav. 2020 Jun 26;111(3):184-194
pubmed: 32624560
PLoS Curr. 2016 Feb 02;8:
pubmed: 27330848
N Engl J Med. 2020 Apr 30;382(18):e41
pubmed: 32212516
J Grad Med Educ. 2018 Aug;10(4):382-384
pubmed: 30154964
Ann Acad Med Singap. 2009 Aug;38(8):724-6
pubmed: 19736579
Thromb Haemost. 2020 Dec;120(12):1725-1732
pubmed: 32828072
Med Teach. 2016 Oct;38(10):1064-1069
pubmed: 27128290
Adv Chronic Kidney Dis. 2020 Sep;27(5):412-417
pubmed: 33308507
Med Teach. 2013 Nov;35(11):e1561-72
pubmed: 24004029
J Contin Educ Health Prof. 2004 Spring;24(2):76-81
pubmed: 15279132
Acad Med. 2021 Jan 1;96(1):56-61
pubmed: 32889947
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Grad Med Educ. 2020 Aug;12(4):403-405
pubmed: 32879676
J Clin Psychol. 2016 Dec;72(12):1318-1332
pubmed: 26990644
AEM Educ Train. 2020 Apr 27;4(3):313-317
pubmed: 32704605
BMJ Open. 2016 Feb 16;6(2):e010460
pubmed: 26883241
Med Teach. 2020 Nov;42(11):1202-1215
pubmed: 32847456
J Thromb Thrombolysis. 2020 Jul;50(1):68-71
pubmed: 32367471
JCO Oncol Pract. 2020 Sep;16(9):e943-e947
pubmed: 32407178

Auteurs

Richard L Martin (RL)

Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN.

Michael J Grant (MJ)

Section of Hematology-Oncology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT.

Stephen Kimani (S)

Department of Medicine, The University of North Carolina, Chapel Hill, NC.

Shonali Midha (S)

H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morsani College of Medicine, Tampa, FL.

Jori May (J)

Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.

Rushad Patell (R)

Division of Hematology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Emily Collier (E)

Section of Hematology-Oncology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT.

David Furfaro (D)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, New York-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY.

Charles Bodine (C)

Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.

Leo Reap (L)

Department of Medicine, Ascension Providence Hospital, Detroit, MI.

Nikesh Shah (N)

H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morsani College of Medicine, Tampa, FL.

Jess DeLaune (J)

Division of Hematology-Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL.

Samuel Brusca (S)

National Institutes of Health Clinical Center, Bethesda, MD.

Coral Olazagasti (C)

Division of Hematology-Oncology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, NY.

Shreya Goyal (S)

Division of Hematology-Oncology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, NY.

Samuel Rubinstein (S)

Division of Hematology, Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

Nausheen Hakim (N)

Division of Hematology-Oncology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra University, Long Island, NY.

Shuai Qin (S)

Division of Hematology-Oncology, Department of Internal Medicine, Loyola University Medical Center, Maywood, IL.

Sabrina L Browning (SL)

Division of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT.

Laura Sena (L)

The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.

Jill Gilbert (J)

Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN.

Mario Davidson (M)

Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN.

Christine M Lovly (CM)

Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN.

Nagashree Seetharamu (N)

Division of Hematology-Oncology, Donald and Barbara Zucker School of Medicine at Hofstra University, New Hyde Park, NY.

Deepa Rangachari (D)

Division of Hematology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Martina Murphy (M)

Division of Hematology-Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL.

Monica Chatwal (M)

H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morsani College of Medicine, Tampa, FL.

Rita Paschal (R)

Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.

Elizabeth Henry (E)

Division of Hematology-Oncology, Department of Internal Medicine, Department of Medical Education, Loyola University Medical Center, Maywood, IL.

Frances Collichio (F)

Division of Hematology Oncology, Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

Jennifer R Green (JR)

Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH